Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy

Uyen Truong, Anita J. Moon-Grady, Lavjay Butani

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Because of its lack of nephrotoxicity, the use of sirolimus, as an immunosuppressive agent, has increased considerably in solid-organ transplant (Tx) recipients. With its increased use, Tx professionals are encountering a variety of previously unreported side-effects such as angioedema and interstitial pneumonitis. We describe here the case of a pediatric renal Tx recipient who, while receiving sirolimus, developed a large pericardial effusion requiring pericardiocentesis. An extensive workup for an infectious etiology was performed; the only positive result was isolation of adenovirus type 2 from the patient's stool specimen. Following sirolimus dose reduction this child's effusion stabilized and has not recurred. The purpose of this report is to advise health-care professionals caring for Tx recipients about this potentially life-threatening complication associated with sirolimus. The role of adenovirus, if any, in contributing to the development of our patient's pericardial effusion is discussed herein.

Original languageEnglish (US)
Pages (from-to)541-544
Number of pages4
JournalPediatric Transplantation
Volume9
Issue number4
DOIs
StatePublished - Aug 2005

Fingerprint

Cardiac Tamponade
Sirolimus
Pediatrics
Kidney
Pericardial Effusion
Adenoviridae
Pericardiocentesis
Angioedema
Interstitial Lung Diseases
Therapeutics
Immunosuppressive Agents
Delivery of Health Care
Transplants
Transplant Recipients

Keywords

  • Effusion
  • Kidney
  • Pericardial
  • Sirolimus
  • Tamponade
  • Transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy. / Truong, Uyen; Moon-Grady, Anita J.; Butani, Lavjay.

In: Pediatric Transplantation, Vol. 9, No. 4, 08.2005, p. 541-544.

Research output: Contribution to journalArticle

@article{dc84808a63264bc798d979cb6fe5338a,
title = "Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy",
abstract = "Because of its lack of nephrotoxicity, the use of sirolimus, as an immunosuppressive agent, has increased considerably in solid-organ transplant (Tx) recipients. With its increased use, Tx professionals are encountering a variety of previously unreported side-effects such as angioedema and interstitial pneumonitis. We describe here the case of a pediatric renal Tx recipient who, while receiving sirolimus, developed a large pericardial effusion requiring pericardiocentesis. An extensive workup for an infectious etiology was performed; the only positive result was isolation of adenovirus type 2 from the patient's stool specimen. Following sirolimus dose reduction this child's effusion stabilized and has not recurred. The purpose of this report is to advise health-care professionals caring for Tx recipients about this potentially life-threatening complication associated with sirolimus. The role of adenovirus, if any, in contributing to the development of our patient's pericardial effusion is discussed herein.",
keywords = "Effusion, Kidney, Pericardial, Sirolimus, Tamponade, Transplantation",
author = "Uyen Truong and Moon-Grady, {Anita J.} and Lavjay Butani",
year = "2005",
month = "8",
doi = "10.1111/j.1399-3046.2005.00323.x",
language = "English (US)",
volume = "9",
pages = "541--544",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy

AU - Truong, Uyen

AU - Moon-Grady, Anita J.

AU - Butani, Lavjay

PY - 2005/8

Y1 - 2005/8

N2 - Because of its lack of nephrotoxicity, the use of sirolimus, as an immunosuppressive agent, has increased considerably in solid-organ transplant (Tx) recipients. With its increased use, Tx professionals are encountering a variety of previously unreported side-effects such as angioedema and interstitial pneumonitis. We describe here the case of a pediatric renal Tx recipient who, while receiving sirolimus, developed a large pericardial effusion requiring pericardiocentesis. An extensive workup for an infectious etiology was performed; the only positive result was isolation of adenovirus type 2 from the patient's stool specimen. Following sirolimus dose reduction this child's effusion stabilized and has not recurred. The purpose of this report is to advise health-care professionals caring for Tx recipients about this potentially life-threatening complication associated with sirolimus. The role of adenovirus, if any, in contributing to the development of our patient's pericardial effusion is discussed herein.

AB - Because of its lack of nephrotoxicity, the use of sirolimus, as an immunosuppressive agent, has increased considerably in solid-organ transplant (Tx) recipients. With its increased use, Tx professionals are encountering a variety of previously unreported side-effects such as angioedema and interstitial pneumonitis. We describe here the case of a pediatric renal Tx recipient who, while receiving sirolimus, developed a large pericardial effusion requiring pericardiocentesis. An extensive workup for an infectious etiology was performed; the only positive result was isolation of adenovirus type 2 from the patient's stool specimen. Following sirolimus dose reduction this child's effusion stabilized and has not recurred. The purpose of this report is to advise health-care professionals caring for Tx recipients about this potentially life-threatening complication associated with sirolimus. The role of adenovirus, if any, in contributing to the development of our patient's pericardial effusion is discussed herein.

KW - Effusion

KW - Kidney

KW - Pericardial

KW - Sirolimus

KW - Tamponade

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=23844457227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844457227&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2005.00323.x

DO - 10.1111/j.1399-3046.2005.00323.x

M3 - Article

VL - 9

SP - 541

EP - 544

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

ER -